Macquarie Group’s Apollo Endosurgery, Inc. APEN Stock Holding History

Macquarie Group’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,984	Closed	-$34K	–	2647
2021 Q4	$34K	Buy	3,984 +2,002	+101%	+$17.5K	﹤0.01%	2276
2021 Q3	$18K	Buy	+1,982	New	+$17K	﹤0.01%	2472
2019 Q1	–	Sell	-1,900	Closed	-$7K	–	2148
2018 Q4	$7K	Buy	+1,900	New	+$9.38K	﹤0.01%	2021

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Macquarie Group's APEN Position: Q1 2022 in Review

Macquarie Group sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2022, closing a stake of 3,984 shares — an estimated $34K sold.

Macquarie Group first reported a position in APEN in Q4 2018 and held it in 3 quarters. The position peaked at $34K in Q4 2021. 71 funds tracked by Wall St. Rank hold APEN as of Q1 2022.

Macquarie Group reported no remaining Apollo Endosurgery, Inc. position as of Q1 2022 after selling out during the quarter.
Macquarie Group sold 3,984 Apollo Endosurgery, Inc. shares in Q1 2022, an estimated $34K.
Macquarie Group first reported a position in Apollo Endosurgery, Inc. in Q4 2018 and held it in 3 quarters.
Macquarie Group's Apollo Endosurgery, Inc. position peaked at $34K in Q4 2021.
71 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2022.

Based on Macquarie Group's 13F filing for Q1 2022, filed 16 May 2022.